Clinical trials for Bronchitis

Information provided by WHO International Clinical Trials Registry

The clinical trials below are relevant to Bronchitis. For all clinical trials, go to clinical trials search

This list shows clinical trials for Bronchitis

Search result filters
Recruitment status
Trials for children:
Country of trial:

You have searched for the following terms

  • Bronchitis
Title Recruitment status Location
A clinical trial to investigate whether a dose of 10mg or 20mg aerolised liposomal ciclosporin A (L-CsA) is safe and effective to prevent Bronchiolitis Obliterans Syndrome (BOS) in lung transplane patients Not Recruiting United Kingdom
An open-label safety extension study for those patients who participated in protocol 10211.201 and wish to continue therapy with L-CsA Not Recruiting United Kingdom
A phase II, multicentre,randomised, double-blind, placebo controlled, parallel group, dose-finding clinical trial to investigate the efficacy and safety of 10 and 20 mg/day aerosolised liposomal ciclosporin A (L-CsA) versus aerosolised placebo in the prevention of bronchiolitis obliterans syndrome (BOS) in lung transplant (LT) patients Ensayo clínico de fase II, multicéntrico, aleatorizado, doble ciego, controlado con placebo, de grupos paralelos y búsqueda de dosis para investigar la eficacia y la seguridad de 10 y 20 mg/día de Ciclosporina A Liposómica aerosolizada (L-CsA) frente a placebo aerosolizado en la prevención del síndrome de bronquiolitis obliterante (SBO) en pacientes con trasplante pulmonar Not Recruiting United Kingdom
A prospective, multinational, multicenter, randomized, double-blind, double-dummy, controlled study comparing the efficacy and safety of moxifloxacin to that of amoxicillin-clavulanic acid for the treatment of subjects with acute exacerbations of chronic bronchitis: MAESTRAL (moxifloxacin in AECB superiority trial) - MAESTRAL Not Recruiting United Kingdom
A phase II, randomised, double-blind, placebo controlled, parallel group, dose-finding clinical trial to investigate the efficacy and safety of 10 and 20 mg/day aerosolised liposomal ciclosporin A (L-CsA) versus placebo in the treatment of bronchiolitis obliterans syndrome (BOS) in allogeneic haematopoietic stem cell transplant (HSCT) patients Not Recruiting United Kingdom
A Phase 2 study to test how effective MEDI8968 is in treating subjects with chronic bronchitis, emphysema, or both, in which airflow to the lungs is restricted. Not Recruiting United Kingdom
A Phase 2 study to test how effective MEDI8968 is in treating subjects with chronic bronchitis, emphysema, or both, in which airflow to the lungs is restricted. Not Recruiting United Kingdom
An open-label safety extension study for those patients who participated in protocol 10211.201 and wish to continue therapy with L-CsA Not Recruiting United Kingdom
A prospective, multinational, multicenter, randomized, double-blind, double-dummy, controlled study comparing the efficacy and safety of moxifloxacin to that of amoxicillin-clavulanic acid for the treatment of subjects with acute exacerbations of chronic bronchitis: MAESTRAL (moxifloxacin in AECB superiority trial) - MAESTRAL Not Recruiting United Kingdom
An open-label safety extension study for those patients who participated in protocol 10211.201 and wish to continue therapy with L-CsA Not Recruiting United Kingdom

Page last reviewed: 20/04/2012

Next review due: 20/04/2014